Prevalence of Type 2 Diabetes Mellitus Among Men in the Middle East: A Retrospective Study
Prevalence of Type 2 Diabetes Mellitus Among Men in the Middle East: A Retrospective Study
复制标题
DOI：
10.1177/1557988319848577
复制
发表时间：
2019-05-01
影响因子：
2.3
通讯作者：
Ullah, Anhar
中科院分区：
文献类型：
--
作者：
Meo, Sultan Ayoub;Sheikh, Saeed A.;Ullah, Anhar
糖尿病（DM）的患病率不断上升，是一个严重的全球性健康问题。世界正在经历2型糖尿病的流行，患病率因性别、地区和社会经济发展水平而异。2型糖尿病（T2 DM）在男性中以更快的速度增加，并且在世界一些地区的数量继续增加。本研究旨在估计中东国家男性中T2 DM的患病率。通过使用关键词“流行病学”、“患病率”、“糖尿病”和中东各州的名称，通过包括Web of Science、Medline、PubMed、EMBASE、Scopus和奥维德数据库在内的搜索引擎确定了74篇研究文章。最后，纳入了17项研究，以评估中东男性T2 DM的患病率。在中东，巴林（33.60%）、沙特阿拉伯（29.10%）、阿拉伯联合酋长国（UAE; 25.83%）和科威特（25.40%）男性T2 DM的患病率较高，而伊朗（9.90%）和也门（9.80%）报告的患病率较低。海湾合作理事会（GCC）国家的随机合并患病率为24.0%，而非GCC国家为16.0%，GCC和非GCC国家合并后的患病率为19%。患病率与这些州的国内生产总值显著相关（p = .0005）。尽管中东地区的社会经济和文化背景不同，但在巴林、沙特阿拉伯、阿联酋和科威特发现男性T2 DM患病率上升。这些国家必须纳入针对中东人口的未来糖尿病防御战略，以最大限度地减少该地区的糖尿病负担。
The rising prevalence of diabetes mellitus (DM) is a serious global health concern. The world is experiencing type 2 diabetes epidemics and prevalence differs by gender, regions, and level of socioeconomic development. Type 2 diabetes mellitus (T2DM) in men increased at a faster rate and numbers are continuing to rise in some regions of the world. This study aimed to estimate the prevalence of T2DM among men in the Middle East countries. Seventy-four research articles were identified through search engines including Web of Science, Medline, PubMed, EMBASE, Scopus, and Ovid databases by using keywords "epidemiology," "prevalence," "diabetes mellitus," and individual names of the Middle East states. Finally, 17 studies were included for the assessment of prevalence of T2DM among men in the Middle East. In the Middle East, high prevalence of T2DM among men was identified in Bahrain (33.60%), Saudi Arabia (29.10%), United Arab Emirates (UAE; 25.83%), and Kuwait (25.40%), whereas low prevalence was reported in Iran (9.90%) and Yemen (9.80%). The random pooled prevalence in the Gulf Cooperation Council (GCC) states was (24.0%) compared to non-GCC states (16.0%), and in both GCC and non-GCC countries combined, it was 19%. The prevalence was significantly associated with the gross domestic product of these states (p = .0005). Despite different socioeconomic and cultural settings in the Middle East, the rising T2DM prevalence among men was identified in Bahrain, Saudi Arabia, UAE, and Kuwait. These states must incorporate future diabetes defensive strategies targeting the Middle East population to minimize the burden of DM from the region.